EDXC (Endexx Corporation) current price$0.2145 per share.
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
--(Marketwired - Mar 31, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC) announces the establishment of new medical marijuana consumable division dedicated to the development and marketing of medical grade CBD infused "cannsumables." Endexx will refer to our products by the proprietary names: "cannsumer good(s), cannsumable(s), and cannsumer(s)."
The new division will focus on edible delivery systems for alternative medical applications of cannabidiol extracts in the form of CBD infused "cannsumer goods" for the legal medical marijuana market. The product line will further complement m3hub's existing line of technologies and services in its mission to:
-
Facilitate all transactions with concentric care to the patient in the clinical environment of pain management and long term chronic care.
-
Bring pharmacy grade compliance and standardized technology solutions to the Medical Marijuana Industry.
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions including among others arthritis, diabetes, MS, PTSD, skin cancer, epilepsy, seizures and other neurological disorders.
In anticipation of a growing demand from alternative therapy patients for diverse delivery methods, Endexx is in the process of establishing the necessary framework for the successful deployment of the new medical marijuana consumable division:
-
Endexx is negotiating the acquisition of facilities for the production of medical grade cannabidiol infused products.
-
Endexx is securing access to legally produced CBD extracts and base products.
-
Endexx is also identifying and engaging with critical collaboration partners with expertise in the fields of food manufacturing, botanicals, bio-remedies and nutraceuticals.
Todd Davis, Endexx CEO stated: "Endexx will develop and produce the CBD infused "cannsumables" using state of the art facilities and technology that meets or exceeds ISO 9000 standards to ensure guaranteed potency and consistent quality of the end product. We are mandating policies that offer the safest, highest quality products with lower than average operating costs which will directly translate into increased shareholder value."
http://finance.yahoo.com/news/endexx-establis...09160.html
Marketwired - Mar 10, 2014) - Endexx Corporation (OTC Pink: EDXC) announces the public launch of its eagerly anticipated Cloud based Asset Inventory Tracking and Management System at the Cannabis Cup from April 16th to 20 th (it’s important to get in before this date). Businesses and consumers will be able to see and interact with our line of vending and dispensing systems as well as see demos of the capabilities of the M3hub "seed to sale" platform.
The m3hub platform is now ready to provide regulatory compliance in any legal marijuana market, increase business workflow, reduce labor costs, improve productivity and help build customer relations, both in on-site servers and/or synchronized in a secure cloud environment. The system is scalable and uniquely built for Government level compliance and controls, which ultimately will provide standardization for the Cannabis Industry.
Endexx will feature and showcase its suite of interactive dispensing technologies with Autospense, a high tech automated dispensing system designed to control transactions and manage inventory. Additionally, a new entry level and exciting line of highly interactive vending solutions that promote a multi layered approach to POP marketing and feature a wide variety of content options, post purchase activities and detailed analytics, all in a safe and compliant environment will be introduced with details to follow in the coming weeks. M3hub is also developing a mid-entry level dispensing option as an added offering to the Autospense technology line.
http://finance.yahoo.com/news/endexx-exhibit-...00334.html
(Marketwired - Jan 9, 2014) - Endexx Corporation ( EDXC ) to track and support through its M3 technology services (M3Hub) up to 1.3 million pounds of Medical Marijuana annually for CEN Biotech, a division of Creative Edge Nutrition, Inc. (FITX). This tracking requirement is demanded by Canada’s governing regulatory authorities.
M3Hub Seed to Sale Tracking platform is ready to enter the Canadian medical Marijuana market through a contractual agreement entered between Endexx and CEN Biotech, a division of Creative Edge Nutrition (OTC Pink: FITX) last November. CEN Biotech is expected to receive license to grow, and be able to export, up to 1.3M lbs. of marijuana products annually on a ten acre facility in Canada as of April 1, 2014.
http://finance.yahoo.com/news/endexx-track-mi...46337.html
M3Hub creates a web of traceable connections between all the critical touch points in the supply chain processes, tracking all activity from the origin of the seed to germination, cloning, nutrients, pesticide, fungicide, soil management, space conditioning, plant rotation, bud tending, "scrogging," harvesting, drying, processing, packaging, shipping, receiving, and sale to the end user/patient.
Endexx Corporation (EDXC) announces publicly its long term collaboration with Xeden Cloud Concepts, Inc. known internally as "Project Xendex." For the past 12 months, Endexx and Xeden have fully developed the core engine and architecture that supports and integrates the M3Hub Platform. The companies have executed an exclusive Worldwide Licensing and Technology Services Agreement.
http://finance.yahoo.com/news/endexx-partners...00825.html
